IPA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally...

Stats
今日成交量	58 154.00
平均成交量	605 622
市值	33.68M
EPS	$0 ( 2024-03-21 )
下一个收益日期	( $-0.100 ) 2024-07-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.12
ATR14	$0.00900 (0.70%)

Insider Trading

Date	Person	Action	Amount	type
2008-12-12	Aisling Capital Ii Lp	Buy	861 826	Convertible 12% Note Due 2009
2008-12-12	Aisling Capital Ii Lp	Buy	10 412	Series D-1 Convertible Preferred Stock
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Sell	10 000	Series C-1 Convertible Preferred Stock

INSIDER POWER
0.00
Last 20 transactions
Buy: 4 917 425 \| Sell: 9 058 105

音量相关性

長: 0.08 (neutral)

短: -0.79 (moderate negative)

Signal:(51.305) Neutral

ImmunoPrecise Antibodies 相关性

10 最正相关
CBNK	0.964
ALRS	0.959
BWB	0.957
WTBA	0.956
UTHR	0.956
KNSA	0.955
HALO	0.952
SFST	0.951
AROW	0.951
WASH	0.95

10 最负相关
DUOL	-0.959
SVFAU	-0.957
LGACU	-0.957
APXI	-0.956
SVFA	-0.953
SCOB	-0.952
DSEY	-0.952
ALTR	-0.951
LGAC	-0.951
NVDA	-0.951

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ImmunoPrecise Antibodies 相关性 - 货币/商品

0.46
( neutral )

0.42
( neutral )

0.00
( neutral )

0.32
( neutral )

-0.50
( neutral )

ImmunoPrecise Antibodies 财务报表

Annual	2022
营收:	$20.67M
毛利润:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
营收:	$20.67M
毛利润:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
营收:	$19.36M
毛利润:	$10.98M (56.72 %)
EPS:	$-0.850

FY	2021
营收:	$17.91M
毛利润:	$11.54M (64.41 %)
EPS:	$-0.450

Financial Reports:

No articles found.

ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.